Hemosiderosis epidemiology and demographics

Hemosiderosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemosiderosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemosiderosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemosiderosis epidemiology and demographics
CDC on Hemosiderosis epidemiology and demographics
Hemosiderosis epidemiology and demographics in the news
Blogs on Hemosiderosis epidemiology and demographics
Directions to Hospitals Treating Hemosiderosis
Risk calculators and risk factors for Hemosiderosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

• The prevalence and incidence of IPH are relatively unknown because of the rare nature.

Age

• IPH is more commonly observed among children. ( approximately 80% of cases are seen in children who are diagnosed in the first decade of life.)
• 205 of cases are adult-onset IPH.

Gender

• IPH affects males and females equally in childhood-onset IPH
• Adult-onset IPH are almost twice as many males as females.
• Males are more commonly affected with IPH than females in adult-onset IPH.

Race

• There is no racial predilection for IPH.